Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 52X45 | — |
patient should be revaccinated after receiving an expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 52X45, expiry date 31-DEC-2024) for prophylaxis. On 17-FEB-2025, the patient received Menveo. On 17-FEB-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: patient should be revaccinated after receiving an expired dose). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 17-FEB-2025 The health care provider called to ask if a patient should be revaccinated after receiving an expired dose of Menveo (1 vial) on the day of reporting. The patient recived expired dose of Menveo which led to, expired vaccine used. The Vaccine Administration Facility is the same as Primary Reporter.